Search the Newsreel

Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance

Cellebrite DI Ltd. (CLBT) reported Q2 EPS of $0.11, exceeding analyst estimates by $0.04, with revenue of $131.14 million. The company provided Q3 2026 revenue guidance of $145-148 million and full-year 2026 revenue guidance of $550-560 million, both slightly below consensus estimates.

Accelerant to Go Private in $4.4B Deal with Thoma Bravo

Accelerant has agreed to be taken private by private-equity firm Thoma Bravo in a deal valued at over $4 billion. Shareholders will receive $20.25 per share in cash, representing a 49% premium over the company's August 12 closing price. The transaction is anticipated to …

Cellectar Biosciences (CLRB) raises $31.7M, flags going concern risk

MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update

MediWound Ltd. EscharEx® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under its BARDA Contract for NexoBrid® Second Quarter Revenue of $3.1 Million; Full-Year 2026 Revenue Guidance of $24–26 …

Cellectar Biosciences 6M 2026: Net loss $(12.6M), Diluted EPS $(1.52) — 10-Q Summary

Cellectar Biosciences reported a consolidated net loss of $(12.6M) and diluted loss per share of $(1.52) for the six months ended June 30, 2026. The company remains pre-revenue but achieved clinical milestones including positive Phase 2 results for CLOVER WaM and FDA Breakthrough Therapy …

Hexcel (HXL), What Is Behind The Fresh Attention?

Hexcel (HXL) has recently garnered attention, with its stock closing at $102.31, reflecting strong recent performance over one year. While one valuation narrative suggests the stock is modestly overvalued at $98.93, another Discounted Cash Flow model indicates a value of $138.03, implying it could …

ArcelorMittal remains Morgan Stanley’s preferred way to invest in European reindustrialisation

Morgan Stanley analyst Alain Gabriel reiterates ArcelorMittal as his preferred investment for European reindustrialisation due to its significant European shipment base and spare capacity. He believes that fiscal support and an assertive "Made in Europe" industrial policy will accelerate industrial reshoring, benefiting European steelmakers …

Suzano Posts Lower 2Q26 Profit but Strong Cash Flow and Closes Kimberly-Clark JV Deal

Suzano Files Mid‑Year 2026 Results Showing Lower Net Sales

Fund Update: 501,775 XCEL ENERGY (XEL) shares added to Magellan Asset Management Ltd portfolio

Magellan Asset Management Ltd has increased its holdings in XCEL ENERGY (XEL) by 501,775 shares, as revealed in a recent SEC 13F filing for the report period ending June 30, 2026. The article also details other significant institutional investor activities, insider trading data, government …

Responsive Playbooks and the TIGO Inflection

This article provides an in-depth AI-generated analysis for Millicom International Cellular S.a. (NASDAQ: TIGO), highlighting neutral near and mid-term readings but a positive long-term bias. It details three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. …

Celebrus Technologies Updates Share Capital After Treasury Share Buyback

Royal Bank of Canada Has $5.70 Million Stake in Celsius Holdings Inc. $CELH

Royal Bank of Canada significantly reduced its stake in Celsius Holdings Inc. by 46.2% in the first quarter, now holding 160,622 shares valued at $5.7 million. Despite this reduction and Celsius missing Q1 revenue and EPS estimates, institutional investors collectively own 60.95% of the …

Celcuity, Inc. (NASDAQ:CELC) Receives Average Recommendation of "Moderate Buy" from Brokerages

Celcuity, Inc. (NASDAQ:CELC) has received an average "Moderate Buy" rating from eleven brokerages, with ten assigning a buy rating and one a sell rating. The average 12-month price target is $155.18, significantly higher than its current price of $92.08. The company recently reported quarterly …

Suzano S.A. reports Q2 results

* Suzano S.A. press release [https://seekingalpha.com/pr/20617622-suzano-reports-adjusted-ebitda-of-r-4_7-billion-in-the-second-quarter-of-2026] (SUZ [https://seekingalpha.com/symbol/SUZ]): Q2 net revenue totalled R$11.6 billion and adjusted EBITDA reached R$4.7 billion, both above the levels recorded in the previous quarter. * Suzano sold 3.3 million tonnes of pulp and paper combined in 2Q26, comprising 2.9 …

Accelerant Holdings (ARX) Earnings Date & Reports & Earnings News

BioXcel Therapeutics (BTAI) Earnings Date and Reports 2026 $BTAI

Celldex Therapeutics (CLDX) Reported Wider Losses, Is It Still Undervalued?

Celldex Therapeutics (CLDX) recently reported wider losses and lower revenue for Q2 and H1 2026, yet its stock has seen significant recent gains. While the company trades at a 4.9x Price-to-Book multiple, suggesting it's overvalued compared to peers, a Discounted Cash Flow (DCF) model …

UPS|United Parcel Service Inc|Price:103.840|Chg%:-0.590

AbCellera Biologics prices oversubscribed $200M offering at $9.75/share

AbCellera Biologics (ABCL [https://seekingalpha.com/symbol/ABCL]) announced the pricing of its oversubscribed underwritten public offering [https://seekingalpha.com/pr/20617674-abcellera-announces-pricing-of-oversubscribed-200-million-public-offering-of-common-shares] of 17.44M common shares at $9.75 per share. In lieu of common shares, AbCellera is also offering pre-funded warrants to purchase up to 3.08M common shares at $9.74999 per warrant …

Is Xcel Energy (XEL) Undervalued As Earnings Strength And Battery Project Interest Build?

Celanese Corp (CE) SVP adds 2,153 shares in open-market stock purchase

Celanese Corp's SVP, Mark Christopher Murray, purchased an additional 2,153 shares of common stock at $45.5199 per share on August 11, 2026, in an open-market transaction. This transaction increased his direct holdings to 30,432 shares of Celanese Common Stock. The filing, a Form 4, …

AbCellera (ABCL) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Chief Legal and Compliance Officer - Tryn Stimart President and Chief Executive Officer - Carl L. Hansen Chief Financial Officer - Andrew Booth Full Conference Call Transcript Operator: …

Celsius Holdings, Inc. (CELH) Stock forecasts

Argus has lowered its target price for Celsius Holdings, Inc. (CELH) to $27.00. The company, which operates in the energy drink market, currently has a stock price of $28.75. The majority of Celsius Holdings' revenue, 95%, comes from North America.

Hexcel Corporation (HXL) Stock Forecasts

Argus has lowered its target price for Hexcel Corporation (HXL) to $111.00. Hexcel, founded in 1948, specializes in engineered composite materials for commercial aerospace, defense, and high-performance automotive sectors. The current stock price for HXL is $102.31.

Suzano Reports Adjusted EBITDA of R$4.7 Billion in the Second Quarter of 2026

Suzano, the world's largest pulp producer, reported solid results for the second quarter of 2026, with Adjusted EBITDA reaching R$4.7 billion and net revenue totaling R$11.6 billion. The company sold 3.3 million tonnes of pulp and paper, demonstrating resilience despite foreign exchange headwinds and …

Suzano Completes $1.3B Arbex Tissue Deal With Kimberly-Clark

Suzano, the world's largest pulp producer, reported strong Q2 2026 results with R$4.7 billion in adjusted EBITDA and R$1.8 billion in net income, driven by higher prices and volumes despite foreign exchange headwinds. Following the quarter, Suzano completed the acquisition of a 51% stake …

Hain Celestial (HAIN) sees 3.5% beneficial stake reported by Charles Schwab

Charles Schwab Investment Management Inc. has filed an amended Schedule 13G, reporting a 3.5% beneficial ownership stake in Hain Celestial Group Inc. As of June 30, 2026, the firm holds 3,162,966 shares with sole voting and dispositive power. This filing classifies their position as …

Celanese (CE) Beat Estimates, So Why Is Guidance Getting Trickier?

Celanese (NYSE:CE) walked into its August 4 earnings call having beaten the plan it laid out back in May, then spent the call flagging a bumpier third quarter ahead. CEO Scott Richardson and CFO Chuck Kyrish explained why: the company's global production network flexed …

Nokia, Celestica, and Applied Optoelectronics Rally After Lumentum Sparks Broad Optics Rally

Quick Read Lumentum's 109% revenue surge and blowout EPS beat dragged Nokia and Celestica each 9% higher in a broad optical sector sympathy rally. Ciena jumped 11% and AAOI added 3% atop a 296% year-to-date gain as the market re-priced AI-driven optical demand across …

Celestica (NYSE:CLS) Trading 9.3% Higher - Here's What Happened

Celestica (NYSE:CLS) shares surged 9.3% to $339.19 on Wednesday with high trading volume, following better-than-expected quarterly earnings and revenue. Analysts maintain a "Moderate Buy" rating with an average price target of $438.86, and several firms recently increased their price targets. Despite the positive performance, …

Suzano Stock Slides As Investors Question Earnings Hype

FuelCell Energy Inc. stock rises Wednesday, outperforms market

FuelCell Energy Inc. (FCEL) stock increased by 12.86% on Wednesday, closing at $21.67. This performance outpaced a mixed market session where the NASDAQ Composite rose, but the Dow Jones Industrial Average slightly declined. The rise ended a two-day losing streak for FuelCell Energy.

Celestica Inc (CLS) director David Reeder granted 133 new D-RSUs

Celestica Inc. director David Reeder was granted 133 Director Restricted Share Units (D-RSUs) on August 11, 2026, as part of an equity compensation. These D-RSUs vest on May 20, 2027, and entitle Reeder to either one common share or an equivalent cash value per …

Celestica Inc (CLS) awards 203 director restricted share units to Francoise Colpron

Celestica Inc (CLS) director Francoise Colpron was granted 203 Director Restricted Share Units (D-RSUs) on August 11, 2026. These D-RSUs represent a contingent right to receive one common share or an equivalent cash value upon settlement and will vest on May 20, 2027. Following …

Bullish Two Hundred Day Moving Average Cross - CLS

In trading on Wednesday, shares of Celestica Inc (Symbol: CLS) crossed above their 200 day moving average of $329.38, changing hands as high as $339.74 per share. Celestica Inc shares are currently trading up about 8.2% on the day. The chart below shows the …